journal article·2019-10-02Open access

Biological Fate of Magnetic Protein-Specific Molecularly Imprinted Polymers: Toxicity and Degradation

Charlotte Boitard, Alberto Curcio, Anne-Laure Rollet, Claire Wilhelm, Christine Ménager, Nébéwia Griffete

ACS Applied Materials & Interfaces· Volume 11· Issue 39

Abstract

Magnetic nanoparticles coated with protein-specific molecularly imprinted polymers (MIPs) are receiving increasing attention thanks to their binding abilities, robustness, and easy synthesis compared to their natural analogues also able to target proteins, such as antibodies or aptamers. Acting as tailor-made recognition systems, protein-specific MIPs can be used in many in vivo nanomedicine applications, such as targeted drug delivery, biosensing, and tissue engineering. Nonetheless, studies on their biocompatibility and long-term fate in biological environments are almost nonexistent, although these questions have to be addressed before considering clinical applications. To alleviate this lack of knowledge, we propose here to monitor the effect of a protein-specific MIP coating on the toxicity and biodegradation of magnetic iron oxide nanoparticles, both in a minimal aqueous degradation medium and in a model of cartilage tissue formed by differentiated human mesenchymal stem cells. Degradation of iron oxide nanoparticles with or without the polymer coating was monitored for a month by following their magnetic properties using vibrating sample magnetometry and their morphology by transmission electron microscopy. We showed that the MIP coating of magnetic iron oxide nanoparticles does not affect their biocompatibility or internalization inside cells. Remarkably, the imprinted polymer coating does not hinder the magnetic particle degradation but seems to slow it down, although this effect is more visible when degradation occurs in the buffer medium than in cells. Hence, the results presented in this paper are really encouraging and open up the way to future applications of MIP-coated nanoparticles into the clinic.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Analytical chemistry methods development · Microfluidic and Capillary Electrophoresis Applications · Biosensors and Analytical Detection

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

CNRS, PHysico-chimie des Electrolytes et Nanosystèmes InterfaciauX, PHENIX, Sorbonne Université, F-75005 Paris, France

Laboratoire Matière et Systèmes Complexes (MSC), UMR 7057, CNRS and Université Paris Diderot, 75205 Paris Cedex 05, France

References (56)

Show source-provided references
1. 10.1073/pnas.11053889710.1073/pnas.110538897 ↗
2. 10.1158/0008-5472.CAN-04-255010.1158/0008-5472.CAN-04-2550 ↗
3. 10.1038/nmeth95310.1038/nmeth953 ↗
4. 10.1038/srep2501910.1038/srep25019 ↗
5. 10.1016/S0014-5793(97)01062-410.1016/S0014-5793(97)01062-4 ↗
6. 10.1096/fj.10-18033110.1096/fj.10-180331 ↗
7. 10.1002/path.254310.1002/path.2543 ↗
8. 10.3390/s12010061210.3390/s120100612 ↗
9. 10.1039/b207596b10.1039/b207596b ↗
10. 10.1016/j.bios.2006.06.02310.1016/j.bios.2006.06.023 ↗
11. 10.1021/la703963f10.1021/la703963f ↗
12. 10.1021/acsami.8b0032710.1021/acsami.8b00327 ↗
13. 10.1021/acs.nanolett.7b0320610.1021/acs.nanolett.7b03206 ↗
14. 10.1038/nchem.274910.1038/nchem.2749 ↗
15. 10.1039/C5NR06133D10.1039/C5NR06133D ↗
16. 10.3109/02656736.2013.82299310.3109/02656736.2013.822993 ↗
17. 10.1002/anie.20130583510.1002/anie.201305835 ↗
18. 10.1016/0730-725X(91)90412-F10.1016/0730-725X(91)90412-F ↗
19. 10.1007/s12274-016-1222-710.1007/s12274-016-1222-7 ↗
20. 10.1021/acs.nanolett.6b0505210.1021/acs.nanolett.6b05052 ↗
21. 10.1021/ja102148f10.1021/ja102148f ↗
22. 10.2214/ajr.152.1.16710.2214/ajr.152.1.167 ↗
23. 10.1007/s00441-004-0884-810.1007/s00441-004-0884-8 ↗
24. 10.3762/bjnano.5.17410.3762/bjnano.5.174 ↗
25. 10.1039/C7PY01603D10.1039/C7PY01603D ↗
26. 10.1021/acsnano.6b0287610.1021/acsnano.6b02876 ↗
27. 10.1073/pnas.181679211610.1073/pnas.1816792116 ↗
28. 10.1039/C7CC04284A10.1039/C7CC04284A ↗
29. 10.1103/PhysRev.94.63010.1103/PhysRev.94.630 ↗
30. 10.1063/1.171629610.1063/1.1716296 ↗
31. 10.1088/0957-4484/21/39/39510310.1088/0957-4484/21/39/395103 ↗
32. 10.1016/j.biomaterials.2011.02.03110.1016/j.biomaterials.2011.02.031 ↗
33. 10.1021/nn300456z10.1021/nn300456z ↗
34. 10.1074/jbc.M00134820010.1074/jbc.M001348200 ↗
35. 10.1021/jp910060c10.1021/jp910060c ↗
36. 10.1039/C5RA16374A10.1039/C5RA16374A ↗
37. 10.1016/j.chroma.2010.06.00110.1016/j.chroma.2010.06.001 ↗
38. 10.1002/nbm.97010.1002/nbm.970 ↗
39. 10.1016/0021-9797(90)90181-M10.1016/0021-9797(90)90181-M ↗
40. 10.1016/S0731-7085(01)00592-110.1016/S0731-7085(01)00592-1 ↗
41. 10.1063/1.47843510.1063/1.478435 ↗
42. 10.1002/wnan.3610.1002/wnan.36 ↗
43. 10.1063/1.487146110.1063/1.4871461 ↗
44. Kimmich R. · 199710.1007/978-3-642-60582-6 ↗
45. 10.1039/C6CP06012A10.1039/C6CP06012A ↗
46. 10.1080/00268976.2018.152741010.1080/00268976.2018.1527410 ↗
47. 10.1002/cmmi.147310.1002/cmmi.1473 ↗
48. 10.1021/nn101129r10.1021/nn101129r ↗
49. 10.3762/bjoc.12.13010.3762/bjoc.12.130 ↗
50. 10.1016/0041-008X(65)90119-510.1016/0041-008X(65)90119-5 ↗
51. Sjöholm I. · J. Pharmacol. Exp. Ther. · 1979 · 211 · 656
52. 10.1002/adfm.20160599710.1002/adfm.201605997 ↗
53. 10.1021/acsnano.8b0048210.1021/acsnano.8b00482 ↗
54. 10.1021/ar030233610.1021/ar0302336 ↗
55. 10.1021/nn305719y10.1021/nn305719y ↗
56. 10.1021/ja800492z10.1021/ja800492z ↗